Clinical Trials Directory

Trials / Conditions / Stage III Bladder Urothelial Carcinoma AJCC v6 and v7

Stage III Bladder Urothelial Carcinoma AJCC v6 and v7

8 registered clinical trials studyying Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Sur
NCT05987241
National Cancer Institute (NCI)Phase 2 / Phase 3
WithdrawnRadiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer
NCT03419130
University of California, San FranciscoPhase 2
CompletedNivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for
NCT03421652
Barbara Ann Karmanos Cancer InstitutePhase 2
Active Not RecruitingTesting MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advance
NCT03244384
National Cancer Institute (NCI)Phase 3
Active Not RecruitingSapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mut
NCT03047213
National Cancer Institute (NCI)Phase 2
Active Not RecruitingDurvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot
NCT02812420
M.D. Anderson Cancer CenterEARLY_Phase 1
CompletedGemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or C
NCT02178241
National Cancer Institute (NCI)Phase 2
Active Not RecruitingEribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney
NCT00365157
National Cancer Institute (NCI)Phase 1 / Phase 2